All In MedTech

Device Trial Radar · NCT04661124

Evaluation of the Heidelberg Engineering SPECTRALIS With Flex Module for In-vivo Imaging in the Supine Position

Last checked: Nov 19, 2026Latest source record: Sep 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

88

Actual

Start

Dec 10, 2020

Primary completion

Sep 17, 2021

Study completion Apr 22, 2024

Sponsor

Lead sponsor
Heidelberg Engineering GmbHNot on our public-company list
Sponsor type
Industry
Collaborators
Duke University
First posted
Dec 10, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a prospective clinical study conducted at one clinical site in the United States.

Conditions

  • Retinal Disease
  • Healthy Eyes

Interventions

  • SPECTRALISDevice

    ophthalmic imaging device with head and chinrest

  • SPECTRALIS with Flex ModuleDevice

    ophthalmic imaging device on mobile instrumentation stand

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The image quality grade of the acquired images as determined by an independent reading centerTime frame: through study completion, average of 1 day
  2. Agreement in identification of abnormalities of the acquired Standard OCT images between the devicesTime frame: through study completion, average of 1 day
  3. Agreement in identification of abnormalities of the acquired OCTA images between the devicesTime frame: through study completion, average of 1 day

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Duke Eye Center

    Durham, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.